DOPAMINE D-1 AND D-2 RECEPTOR LIGANDS MODULATE THE BEHAVIOR OF MICE IN THE ELEVATED PLUS-MAZE

被引:114
作者
RODGERS, RJ [1 ]
NIKULINA, EM [1 ]
COLE, JC [1 ]
机构
[1] RUSSIAN ACAD SCI, INST CYTOL & GENET, NOVOSIBIRSK 630090, RUSSIA
基金
英国医学研究理事会;
关键词
ELEVATED PLUS-MAZE; ETHOLOGICAL ANALYSIS; RISK ASSESSMENT; DOPAMINE; SKF; 38393; SCH-23390; QUINPIROLE; SULPIRIDE;
D O I
10.1016/0091-3057(94)90253-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
To further our understanding of the potential role of dopamine in mechanisms of anxiety, the effects fo four dopamine receptor ligands were examined in an ethological version of the murine elevated plus-maze test. The D-1 receptor partial agonist SKF 38393 (2.5-20.0 mg/kg), had minimal behavioural activity in this teat, whereas the selective D-1 receptor antagonist, SCH 23390 (0.025-0.2 mg/kg), had dose-dependent but behaviourally nonspecific effects. Quinpirole (0.0625-0.5 mg/kg), a D-2 receptor agonist, had no effects at low doses but severely disrupted locomotion and exploration at the highest doses tested. In marked contrast to the lack of effect or nonspecific effects seen with the other ligands tested, the D-2 receptor antagonist, sulpiride (2.5-20.0 mg/kg), produced an unambiguous anxiolytic-like profile under present test conditions. Although non of the doses tested adversely affected general activity, clear antianxiety effects were observed on both traditional and novel (i.e., risk assessment) behavioural measures. Data are discussed in relation to the relative importance D-1 and D-2 receptor mechanisms in plus-maze anxiety, and the need to further assess D-2 involvement through the use of more selective compounds.
引用
收藏
页码:985 / 995
页数:11
相关论文
共 64 条
[1]   DOPAMINE D-1 RECEPTOR AGONISTS COMBINED WITH THE SELECTIVE D-2 AGONIST QUINPIROLE FACILITATE THE EXPRESSION OF ORAL STEREOTYPED BEHAVIOR IN RATS [J].
ARNT, J ;
HYTTEL, J ;
PERREGAARD, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (02) :137-145
[2]   LY 171555-INDUCED HYPERDEFENSIVENESS IN THE MOUSE DOES NOT IMPLICATE BENZODIAZEPINE RECEPTORS [J].
BELZUNG, C ;
CABIB, S ;
FABIANI, L ;
TOLENTINO, P ;
PUGLISIALLEGRA, S .
PSYCHOPHARMACOLOGY, 1991, 103 (04) :449-454
[3]   BEHAVIORAL-EFFECTS OF RO-41-9067 - A NOVEL D2 DOPAMINE RECEPTOR AGONIST [J].
BELZUNG, C ;
CARLETTI, P ;
ANGELUCCI, F ;
PUGLISIALLEGRA, S ;
CABIB, S .
DRUG DEVELOPMENT RESEARCH, 1992, 27 (04) :425-433
[4]   THE CHARACTERIZATION AND MODELING OF ANTIPREDATOR DEFENSIVE BEHAVIOR [J].
BLANCHARD, RJ ;
BLANCHARD, DC ;
RODGERS, J ;
WEISS, SM .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1990, 14 (04) :463-472
[5]   EFFECTS OF IMMOBILIZATION STRESS ON DOPAMINE AND ITS METABOLITES IN DIFFERENT BRAIN-AREAS OF THE MOUSE - ROLE OF GENOTYPE AND STRESS DURATION [J].
CABIB, S ;
KEMPF, E ;
SCHLEEF, C ;
OLIVERIO, A ;
PUGLISIALLEGRA, S .
BRAIN RESEARCH, 1988, 441 (1-2) :153-160
[6]   GENOTYPE-DEPENDENT MODULATION OF LY-171555-INDUCED DEFENSIVE BEHAVIOR IN THE MOUSE [J].
CABIB, S ;
PUGLISIALLEGRA, S .
PSYCHOPHARMACOLOGY, 1989, 97 (02) :166-168
[7]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[8]   REVIEW - D1 DOPAMINE RECEPTOR - THE SEARCH FOR A FUNCTION - A CRITICAL-EVALUATION OF THE D1/D2 DOPAMINE RECEPTOR CLASSIFICATION AND ITS FUNCTIONAL IMPLICATIONS [J].
CLARK, D ;
WHITE, FJ .
SYNAPSE, 1987, 1 (04) :347-388
[9]  
COLE JC, 1993, BEHAV PHARMACOL, V4, P573
[10]   ETHOLOGICAL EVALUATION OF THE EFFECTS OF ACUTE AND CHRONIC BUSPIRONE TREATMENT IN THE MURINE ELEVATED PLUS-MAZE TEST - COMPARISON WITH HALOPERIDOL [J].
COLE, JC ;
RODGERS, RJ .
PSYCHOPHARMACOLOGY, 1994, 114 (02) :288-296